Unknown

Dataset Information

0

In silico analysis of the substitution mutations and evolutionary trends of the SARS-CoV-2 structural proteins in Asia.


ABSTRACT:

Objectives

To address a highly mutable pathogen, mutations must be evaluated. SARS-CoV-2 involves changing infectivity, mortality, and treatment and vaccination susceptibility resulting from mutations.

Materials and methods

We investigated the Asian and worldwide samples of amino-acid sequences (AASs) for envelope (E), membrane (M), nucleocapsid (N), and spike (S) proteins from the announcement of the new coronavirus 2019 (COVID-19) up to January 2022. Sequence alignment to the Wuhan-2019 virus permits tracking mutations in Asian and global samples. Furthermore, we explored the evolutionary tendencies of structural protein mutations and compared the results between Asia and the globe.

Results

The mutation analyses indicated that 5.81%, 70.63%, 26.59%, and 3.36% of Asian S, E, M, and N samples did not display any mutation. Additionally, the most relative mutations among the S, E, M, and N AASs occurred in the regions of 508 to 635 AA, 7 to 14 AA, 66 to 88 AA, and 164 to 205 AA in both Asian and total samples. D614G, T9I, I82T, and R203M were inferred as the most frequent mutations in S, E, M, and N AASs. Timeline research showed that substitution mutation in the location of 614 among Asian and total S AASs was detected from January 2020.

Conclusion

N protein was the most non-conserved protein, and the most prevalent mutations in S, E, M, and N AASs were D614G, T9I, I82T, and R203M. Screening structural protein mutations is a robust approach for developing drugs, vaccines, and more specific diagnostic tools.

SUBMITTER: Abavisani M 

PROVIDER: S-EPMC9699957 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

<i>In silico</i> analysis of the substitution mutations and evolutionary trends of the SARS-CoV-2 structural proteins in Asia.

Abavisani Mohammad M   Rahimian Karim K   Kodori Mansoor M   Khayami Reza R   Mollapour Sisakht Mahsa M   Mahmanzar Mohammadamin M   Meshkat Zahra Z  

Iranian journal of basic medical sciences 20221101 11


<h4>Objectives</h4>To address a highly mutable pathogen, mutations must be evaluated. SARS-CoV-2 involves changing infectivity, mortality, and treatment and vaccination susceptibility resulting from mutations.<h4>Materials and methods</h4>We investigated the Asian and worldwide samples of amino-acid sequences (AASs) for envelope (E), membrane (M), nucleocapsid (N), and spike (S) proteins from the announcement of the new coronavirus 2019 (COVID-19) up to January 2022. Sequence alignment to the Wu  ...[more]

Similar Datasets

| S-EPMC8043164 | biostudies-literature
| S-EPMC9158474 | biostudies-literature
| S-EPMC7953981 | biostudies-literature
| S-EPMC9759450 | biostudies-literature
| S-EPMC11359407 | biostudies-literature
| S-EPMC7232164 | biostudies-literature
2022-09-28 | GSE182849 | GEO
| S-EPMC11459942 | biostudies-literature
| S-EPMC8139424 | biostudies-literature
| S-EPMC10455537 | biostudies-literature